With its first drug on the market and a pipeline full of catalysts, the company asks investors to weigh a powerful growth story against an elevated valuation and a history of volatility.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of plozasiran in patients with severe hypertriglyceridemia ...

With training camp around the corner, I asked Grok to simulate the Kansas City Chiefs' 2026 NFL season. It was surprisingly ...

When evaluating NFL quarterbacks, touchdown passes and passing yards usually dominate the conversation. But interceptions ...

The Kansas City Chiefs have released renderings of what their new stadium in Kansas will look like, according to ESPN's Adam ...

The translucent ETFE roof will fully enclose the 70,000 Kansas City Chiefs fans when the new stadium opens in Kansas in 2031 ...

The Chiefs dropped the first look at the new $3 billion stadium in Kansas.

The selection of local firms is not a surprise to those in the industry.

The Oklahoma City Thunder's new $900 million stadium has completed a huge milestone as the base work for the arena begins.

The recent approval of enlicitide was seen as a boon for some clinical scenarios, although real-world impact remains to be ...

The Kansas City Chiefs received some much-needed great news ahead of training camp. Golden J opens this week's episode of the ...

A road trip through New England revealed the region’s vast cultural legacy - Taking in the houses of literary giants such as ...